The treatment threshold probability<br /> after clinical examination in the theory of medical decision making
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2004, Vol 21, Issue 3
Abstract
The treatment threshold probability after clinical examination is by definition the disease probability when the expected value of treatment is equal to the expected value of no treatment-“attentive waiting”. The outcomes are distinguished proportionately by the number and the content into dichotomous and polytomous. In dichotomous outcomes with zero value (i.e. death) the treatment threshold after clinical examination (P*) will be: P*=1/ (B/C+1), while in dichotomous outcomes with a value other than or in polytomous outcomes, the treatment threshold after clinical examination is connected with the expected benefit (EB) and expected harm (EC) as follows: P*=1/(EB/EC+1). In a clinical problem with diagnostic uncertainty the following formulae apply: (a) If P(D+)>P* and EV(Rx+)>EV(Rx–), then the treatment is certain. (b) If P(D+)EV(Rx–), then no treatment or “attentive waiting” is the preferable solution. (c) If P(D+)EV(Rx–), then treatment is not given, but an attempt is made with diagnostic test or tests to increase the probability of disease presence (the positive predictive value of test to approach a). (d) If P(D+)>P* and EV(Rx+)< EV(Rx–), then treatment is not given, but reinvestigation of literature is indicated for the existence of random error in the “predominance” treatment choice, and (e) if P(D+)=P* and EV(Rx+EV(Rx–), then the principle of indifference applies. If treatment is applied, for each patient who is correctly treated, P(D+)/P(D–) non-patients will be treated mistakenly
Authors and Affiliations
A. KALLIAKMANIS
Το όψιμο ισχαιμικό preconditioning μειώνει τη βλάβη του νωτιαίου μυελού μετά από αποκλεισμό της κατιούσας θωρακικής αορτής
ΣΚΟΠΟΣ Το ισχαιμικό preconditioning έχει βρεθεί ότι προστατεύει διάφορα όργανα από μια επόμενη μεγαλύτερη ισχαιμία. Στην παρούσα μελέτη, διερευνήθηκε εάν το όψιμο ισχαιμικό preconditioning μειώνει τη βλάβη του νωτιαίου μ...
Causal criteria and investigation of causal connections in health sciences
Most studies in health sciences investigate the etiology of diseases. Data which are collected from applied research provide the possibility to investigate the relation between disease frequency and the characteristics...
Fabry’s disease
Fabry’s disease (FD), an X-linked hereditary metabolic progressive disorder, is due to low or absent activity of the enzyme α-galactosidase A. Human α-galactosidase A is the lysosomal exoglycosidase responsible for the h...
The contribution of walking tests in the assessment of the severity of cardiovascular and respiratory diseases
Prolongation of survival and improvement of the quality of life constitute the ultimate targets of the management of chronic respiratory and cardiovascular diseases. Decreased functional capacity is the most debilitating...
Clinical manifestations and epidemiology of Campylobacter spp infection
Campylobacter infection usually causes enteritis, the nosological spectrum of which varies from watery, non-bloody diarrhea to severe inflammatory diarrhea with abdominal pain and fever. Bacteremia, Reiter syndrome, Guil...